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Background: CRE rates in India are between 15% to 60% in var-
ious studies. Poor infection control practices have ensured that the
incidence of these organisms is on the rise. We hope to highlight
the impact of these infections in terms of mortality and length of
stay in hospital.
Methods & Materials: Consecutive patients admitted during
24 months (1st January 2011 to 31st December 2012) with CR -
Klebsiella isolates from any site where included. The patient was
evaluated clinically and with APACHE-II scores done at a time
nearest to the sampling and also followed up for modiﬁcation of
antibiotic therapy based on culture reports, and ﬁnally the out-
come (death or discharge as cured from the hospital). Assuming
a mortality of 40% for serious CR-Klebsiella infections (BSI) from
published data, sample strength of 58 was calculated for ade-
quately powering the study at 95% CI & 5% error. Fischer’s Exact
Test was used for analysing the statistical signiﬁcance of out-
come differences between Colistin based therapy and non-Colistin
based therapy. Absolute mortality and Severity Adjusted Mortal-
ity (SAM=observedmortality/expectedmortality as per APACHE-II
scores X 100) were calculated.
Results: A) Out of 87 isolates 59 were proven infections. Most
common site of infection was urinary, followed by blood stream
infection, pneumonia and skin & soft tissue.
B) The mean age of cases was 53.6 years. 64% were males and
36% were females
C) The absolute mortality in infections was–25% for UTI, 46% for
Pneumonia, 33.3% for BSI and 9.1% for SSTI. The Severity Adjusted
Mortality was 100 for UTI, 60.6 for SSTI, 184.4 for pneumonia and
222.2 for BSI.
D) The ALOS was 20.2 days, 42% had more than 7 days of hospi-
talization before isolating the CR- Klebsiella.
Conclusion: Carbapenem resistant Klebsiella infections are
associated with high mortality (SAM>100 especially for pneu-
monia and blood stream infections). The study was possible not
powered to make a comparison between various antibiotic regi-
mens. CR Klebsiella infections are associated with signiﬁcantly
prolonged length of stay–both before isolation and after infection.
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Excess mortality due to KPC-producing
Klebsiella pneumoniae in liver transplant
recipients
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Busch, J. Mössner, M. Bartels, U.X. Kaisers
Leipzig University Hospital, Leipzig, Germany
Background: Nosocomial infections in immunocompromised
patients frequently originate from the Gram-negative bacterium
Klebsiella pneumoniae (KP). Treatment options are considerably
restrictedby theemergenceof carbapenem-resistant strains.Organ
transplant recipients are especially at risk for peri-interventional
infections by multidrug-resistant bacteria, however, only little is
known on the impact of K. pneumoniae carbapenemases (KPCs)
producing pathogens in this setting yet.
Methods & Materials: Among 103 patients either colonized
or infected with KPC-2-producing KP (KPC-2-KP) during a large
hospital outbreak, we identiﬁed 9 KPC-positive patients, who
had undergone orthotopic liver transplantation (LTx) between
15.09.2010 and 14.09.2011 at the Leipzig University Hospi-
tal, Germany. Presence of KPC-2-KP was conﬁrmed by culture
and molecular typing was performed using pulsed-ﬁeld gel-
electrophoresis (PFGE). The data from these n=9 LTR were
retrospectively compared to a matched cohort of n =35 LTR (trans-
planted from 2008 to 2011) with proof of invasive infections due
to carbapenem-susceptible Klebsiella spp. strains (69% KP, 31% K.
oxytoca), including a high proportion of ESBL-producers (71%). All
patients were followed up for 6 months after LTx.
Results: 89% (8/9) of KPC-2-KP-positive LTRprogressed to infec-
tion (50% pneumonia, 25% surgical site infections, 25% tertiary
peritonitis), and in 56% (5/9) bloodstream infection with KPC-2-KP
was conﬁrmed. Matched comparison showed a hospital mortality
rate of 78% (LTR with KPC-2-KP) compared to 34% in the remaining
patients (P=0.027). Six-month survival in KPC-positive LTR (22%)
was signiﬁcantly lower compared to LTR with sensitive Klebsiella
strains (70%), and LTR with ESBL-producing Klebsiella strains (64%)
(P<0.05).
Conclusion: We conclude that colonization with carbapenem-
resistant Enterobacteriaceae (CRE) like KPC-2-KP in LTR leads to
high infection rates and excess mortality. Therefore, frequent
screening for CRE in patients on LTx waiting lists appears reason-
able. Although active surveillance studies have demonstrated high
infection rates associated with excess mortality, colonization with
CRE is so far not considered a contraindication to LTx. This position
might need re-evaluation with respect to the fundamental difﬁcul-
ties of graft allocation due to severe organ shortage in countries
like Germany. In our opinion, currently available data do not jus-
tify to consider patients with end-stage liver disease and evidence
of persistent colonization by CRE failing decolonization efforts for
LTx.
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